Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma is a research paper published in Pediatric Blood & Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
GlaxoSmithKline
Grant: R35 CA220500
GlaxoSmithKline
Grant: K12 HD04324
GlaxoSmithKline
Grant: K08β7K08CA194162β02
GlaxoSmithKline
Grant: T32GM008562
NCI NIH HHS
Grant: K08 CA194162
NCI NIH HHS
Grant: P30 CA016520
NIH HHS
Grant: K08-7K08CA194162-02
NICHD NIH HHS
Grant: K12 HD043245
MeSH Terms
Keywords